No Data
Warning! US experts are concerned that if the bird flu virus mutates and evolves, a pandemic may occur.
This round of bird flu transmission has the characteristic of wide spread and extremely strong infectivity. At present, apart from Australia, relevant cases have been reported in other continents around the world. In addition to livestock, there have been several cases of human infection with avian flu virus this year, which has greatly alarmed the academic community. Former director of the US Centers for Disease Control and Prevention warned that humans may face a pandemic of bird flu.
Forecasting The Future: 4 Analyst Projections For Gritstone Bio
During the last three months, 4 analysts shared their evaluations of Gritstone Bio (NASDAQ:GRTS), revealing diverse outlooks from bullish to bearish.In the table below, you'll find a summary of their
JMP Securities Reiterates Market Outperform on Gritstone Bio, Maintains $5 Price Target
JMP Securities analyst Roy Buchanan reiterates Gritstone Bio (NASDAQ:GRTS) with a Market Outperform and maintains $5 price target.
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
JMP Securities analyst Roy Buchanan maintains $Gritstone Bio(GRTS.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 32.2% and a
Express News | Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Gritstone Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PDF Version EMERYVILLE, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccine